2022 in Review: Best in MBC with Dr. Erika Hamilton
Quality of Life, Clinical Research, Novel Treatments, Challenges and Barriers, Medical Community, Clinical Trials Process, Obstacles to Better Outcomes Our MBClife Quality of Life, Clinical Research, Novel Treatments, Challenges and Barriers, Medical Community, Clinical Trials Process, Obstacles to Better Outcomes Our MBClife

2022 in Review: Best in MBC with Dr. Erika Hamilton

Welcome to the first Road to A Cure episode of Season 6. Our guest is the incomparable Dr. Erika Hamilton, a breast oncologist and researcher who, as she says herself, doesn’t shy away from difficult questions. In this episode, we get a review—subtype by subtype—of the biggest news over the past 15 months. Of course, we also talk about what is on the horizon in MBC.

Read More
Road to a Cure - ADC & SARM
Novel Treatments, Medical Community, Challenges and Barriers, Health Disparities, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Immunotherapy, Difficult to Treat, Clinical Research, Long Term Adverse Effects Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, Health Disparities, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Immunotherapy, Difficult to Treat, Clinical Research, Long Term Adverse Effects Our MBClife

Road to a Cure - ADC & SARM

How famous is Dr Hope Rugo? She belongs to a tiny elite group of oncologists who have their own Wikipedia page. Dr. Dennis Slamon is quite possibly the only other member. Enough said. No surprise that we can’t wait to hear what she has to say about a new class of drugs, known as ADCs and specifically, the first ADC for mTNBC that already has a nickname – Sassy (sacituzumab govitecan). Do you know what a SARM is? It is a special class of drugs for those who are Androgen Receptor (AR) positive. Listen and find out.

Read More
Road to a Cure - use of immunotherapy
Immunotherapy, MBC Stories, Patient Advocates, Novel Treatments, Medical Community, Challenges and Barriers, Clinical Trials Process, Difficult to Treat, Obstacles to Better Outcomes, Entities of Cancer, MBC Imaging and Profiling Our MBClife Immunotherapy, MBC Stories, Patient Advocates, Novel Treatments, Medical Community, Challenges and Barriers, Clinical Trials Process, Difficult to Treat, Obstacles to Better Outcomes, Entities of Cancer, MBC Imaging and Profiling Our MBClife

Road to a Cure - use of immunotherapy

This week we are visiting Dr Stephanie Goff at the NIH in Bethesda, Maryland. Dr Goff is a surgical oncologist and a senior member of a research team led by Dr. Steven A. Rosenberg, a man widely regarded as the father of immunotherapy. A friend, who knows a thing or two about this place. is joining us on this trip. Her name is Judy Perkins, and she is the first MBC patient who has been cured by a revolutionary immunotherapy treatment, known as adoptive cell therapy, that was administered by Dr Goff and her colleagues at the NCI.

Read More
Road to a Cure - what it means to us
Living with MBC, MBC Allies, Novel Treatments, MBC Patients, Making Our Best MBC Life, MBC Stories, Relationships and Communication Our MBClife Living with MBC, MBC Allies, Novel Treatments, MBC Patients, Making Our Best MBC Life, MBC Stories, Relationships and Communication Our MBClife

Road to a Cure - what it means to us

The podcast team has embarked upon something quite ambitious. The members of the team have traveled virtually to speak with the leading clinicians and researchers in the field of breast cancer, specifically on the topic of where we are in terms of a cure for metastatic breast cancer. It is impossible to cover it in a neat single episode, so, instead, we created a very special series of episodes that we call “Road to A Cure.” In this premiere episode the members of the creative team share with the audience what it means to live with an incurable disease. We talk about a possibility of a cure, address the real fear of hoping, and tackle these and many other important issues.

Read More